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A Third Locus Predisposing to Multiple Deletions of
mtDNA in Autosomal Dominant Progressive External
Ophthalmoplegia
To the Editor:
Autosomal dominant progressive external ophthalmo-
plegia (adPEO) is a mitochondrial disorder characterized
clinically by ptosis and progressive muscle weak-
ness—most severely affecting the external eye mus-
cles—with disease onset in early adulthood. Ataxia, dys-
phagia, sensorineural hypoacusia, neuropathy, tremor,
cataract, and/or depression are present in some families
(Zeviani et al. 1989, 1990; Servidei et al. 1991; Suo-
malainen et al. 1992; Melberg et al. 1996). In a Swedish
adPEO family, hypogonadism cosegregated with the dis-
ease (Melberg et al. 1996). The typical morphological
findings are ragged red fibers in the modified Gomori
trichrome staining of muscle samples, and accumulation,
enlargement, and abnormal shape of the mitochondria,
on electron microscopy. Moderate reduction of the ac-
tivities of respiratory-chain complexes I and IV is de-
tected in biochemical analysis, and mtDNA analysis
shows multiple mtDNA deletions in muscle samples
(Zeviani et al. 1990; Servidei et al. 1991; Suomalainen
et al. 1992, 1997).
We have shown previously that adPEO is a genetically
heterogeneous disorder, by assigning two distinct ge-
nomic loci; one, in a Finnish family, on 10q24 (MIM
157640; Suomalainen et al. 1995) and the other, in three
Italian families, on 3p14-21 (MIM 601226; Kaukonen
et al. 1996). However, several adPEO families studied
showed exclusion of both of these loci, thus indicating
the existence of one or more additional adPEO loci
(MIM 601227; Suomalainen et al. 1995; Kaukonen et
al. 1996). Here we report a genomewide search and the
assignment of a third adPEO locus.
Figure 1 shows the adPEO pedigree used in the ge-
nome scan, and figure 2 shows Southern blot–hy-
bridization analyses of muscle mtDNA of patient 306
and a healthy control. The affected status was deter-
mined by observation of marked clinical symptoms in
the neurological examination and/or by detection of
multiple mtDNA deletions in the analysis of the muscle-
biopsy specimen. Muscle samples from patients 306 and
408 were examined. The clinical symptoms in this family
were milder than those in families with linkage to the
10q and 3p loci (Suomalainen et al 1995; Kaukonen et
al. 1996). All the patients had progressive external
ophthalmoplegia and ptosis but had no generalized mus-
cle weakness. Age at onset was ∼35 years. Several af-
fected family members had sensorineural hypoacusia.
Two subjects had goiter associated with hypo- or hy-
perthyroidism (patients 305 and 306, respectively). Two
elderly subjects (patients 310 and 311) suffered from
dementia manifesting as impairment of the cognitive
functions, with no affective component. An increased
serum-lactate level at rest was detected in one patient
(patient 408). A typical example of a patient in this
family is patient 306, who at age 67 years had ptosis
and ophthalmoplegia, bilateral hearing loss, and hyper-
thyroidism with goiter. Her standard electromyogram
was myopathic. Nerve conduction–velocity studies were
normal. Multiple mtDNA deletions were detected in an
analysis of muscle specimen from the biceps brachialis.
Histological analysis of her muscle sample revealed that
3% of the fibers were ragged red and 5% showed partial
COX deficiency. No elevation of lactic acid was detected
at rest or after standard exercise, and her serum creatine-
phosphokinase level was within the normal range. Res-
piratory-chain analysis showed slightly reduced activities
of complexes III and IV (65%–70% of controls’ mean),
whereas activities of complexes I and II were within the
normal range. Informed consent was obtained from all
family members, and total DNA was extracted from
lymphoblasts or from 10–150 mg of frozen muscle, as
described by Zeviani et al. (1988). Southern blot anal-
ysis, with PvuII restriction digestion of total DNA, prep-
aration of total human mtDNA as the hybridization
probe, and PCR amplifications to detect mtDNA dele-
tions, were conducted as described elsewhere (Zeviani
et al 1988; Kaukonen et al. 1996). g[32P]-ATP–labeled,
PCR-amplified microsatellite markers were separated
onto a 5% denaturing polyacrylamide gel and visualized
by autoradiography. Fluorescently labeled PCR-ampli-
fied microsatellite markers were typed by use of a model
377 Applied Biosystems automatic sequencer (Perkin-
Elmer).
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Figure 1 adPEO family with linkage to the markers on chromosome 4q. The individuals with marked clinical symptoms and/or deletions
of mtDNA detected by PCR or Southern blot–hybridization analyses are indicated by blackened symbols. The unblackened symbols indicate
clinically healthy individuals age 145 years. The markers used in the haplotype construction are shown in the upper-left corner of the figure.
The boxes around the haplotypes indicate the shared regions of the affected chromosomes. The recombination events limit the adPEO region,
between D4S2924 and D4S2920, to within a distance of 13.5 cM.
The marker set used for the genomewide gene search
was chosen by use of marker-location information ob-
tained from Ge´ne´thon (Dib et al. 1996), the Cooperative
Human Linkage Center, and the Genetic Location Da-
tabase (LDB), with an average intermarker spacing of
15 cM. An autosomal dominant model was used in link-
age calculations, and the frequency of the disease allele
was estimated to be .00001. To avoid the potential dan-
ger of considering young, clinically unaffected, and non-
muscle-biopsied patients as healthy, we performed the
primary calculations as an affected-only analysis, using
even-allele frequencies for each marker allele. Indi-
viduals with marked clinical symptoms and/or multiple
mtDNA deletions in their muscle were considered to be
affected, and all other family members were considered
to have an “unknown” affected status. We performed
chromosome 4q calculations also by considering the
clinically healthy family members age 145 years to be
healthy, with .8 penetrance to allow for exceptionally
late appearance of the disease.
Data-simulation analyses were performed with the
SLINK and MSIM options of the LINKAGE package
(Ott 1989; Weeks et al. 1990). We calculated the average
expected LOD score from 2,000 replicates with a five-
allele marker, using even-allele frequencies, to be 3.34
( ) at recombination fraction (v) of .0 with theSD  0.62
affected-only model, and to be 4.23 ( ) whenSD  0.92
information from clinically healthy family members age
145 years was included. The pairwise and multipoint
LOD-score values were calculated with the FASTLINK
option (Cottingham et al. 1993; Schaffer et al. 1994) of
the MLINK and LINKMAP programs of LINKAGE (La-
throp et al. 1984).
The two known adPEO loci on chromosomes 10q24
and 3p14-21 were first analyzed by genotyping the
markers linked to these loci, as described elsewhere
(Suomalainen et al. 1995; Kaukonen et al. 1996). These
loci were unequivocally excluded from carrying the dis-
ease gene in this family, on the basis of haplotype con-
struction and multipoint linkage analyses done across
the critical regions. Many recombination events were
detected in the disease chromosomes, and the multipoint
LOD scores were !2 across the entire regions of in-
terest (data not shown).
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Figure 2 Southern blot–hybridization analysis of total muscle
DNA, with full-length mtDNA as a probe. Muscle DNA of patient
306, showing normal-size mtDNA of 16.6 kb (arrowhead), and ad-
ditional bands of lower molecular weight, representing mtDNA pop-
ulations with multiple large deletions (lane 1) and a muscle sample
from a control individual with no mitochondrial disease, with only
normal-size mtDNA molecules (lane 2) are shown.
Table 1
Pairwise LOD Scores of Chromosome 4q Markers
MARKER AND
ANALYSISa
MAXIMUM LOD SCORE AT v 
.00 .01 .05 .10 .15
D4S1554:
1 1.61 1.57 1.38 1.15 .92
2 2.28 2.22 1.99 1.70 1.41
D4S2920:
1  .44 .93 .96 .85
2  1.32 1.74 1.69 1.51
D4S2954:
1 1.29 1.25 1.10 .92 .75
2 1.73 1.68 1.51 1.29 1.08
D4S1535:
1 2.62 2.56 2.30 1.98 1.64
2 3.51 3.43 3.12 2.72 2.30
D4S408:
1 1.89 1.85 1.65 1.41 1.18
2 2.34 2.29 2.10 1.85 1.60
D4S171:
1 1.75 1.72 1.59 1.42 1.23
2 1.86 1.83 1.72 1.55 1.36
D4S2924:
1 1.97 1.91 1.71 1.46 1.22
2 1.68 1.65 1.53 1.37 1.19
D4S2299:
1  1.80 .56 .16 .02
2  .98 .20 .52 .59
a “1” denotes affected-only analyses, and “2” denotes analyses done
with inclusion of clinically healthy individuals age 145 years, with .8
penetrance. Pedigree of the family is shown in figure 1.
After analysis of 315 markers, primary evidence of
linkage was obtained with marker D4S408, which pro-
vided two-point LOD scores of 1.89, with the affected-
only model, and 2.34, with the inclusion of clinically
normal family members age 145 years as healthy, with
.8 penetrance in the linkage calculations (table 1). Hap-
lotypes across this chromosomal region were con-
structed with informative markers D4S1554, D4S2920,
D4S2954, D4S1535, D4S408, D4S171, D4S2924, and
D4S2299. Recombination events detected in subjects
306 and 402 (fig. 1) limit the third adPEO locus to !13.5
cM, between markers D4S2920 and D4S2924, on 4q34-
35. The intermarker distances and cytogenetic locali-
zation of this adPEO locus were established by use of
the mapping information of the LDB.
The same set of 4q markers was used in pairwise and
multipoint linkage calculations. The best two-point
LOD scores obtained were 2.62, with marker D4S1535
(affected-only model), and 3.51, when clinically healthy
family members age 145 years were considered healthy,
with .8 penetrance. The affected-only multipoint cal-
culations across the critical region gave a maximum
LOD score of 3.8; 4.7 was obtained when data on the
healthy family members were included in the analyses
(fig. 3).
Our sample contained four informative Italian fami-
lies with adPEO (each family alone was informative
enough to provide the maximum expected LOD score
of 12 at , with 2,000 replicates) not previouslyv  .01
assigned to known adPEO loci. To study the possible
linkage to the 4q locus in these families, haplotypes were
constructed across the entire 4q adPEO region. Many
recombination events were observed across the region
in the disease chromosomes, and the multipoint calcu-
lations across the region remained !2 (data not
shown), thus clearly excluding the chromosome 4 locus
as the cause of the disease in these families.
adPEO appears to be a genetically heterogeneous dis-
order, with at least four different nuclear loci causing
very similar phenotypes. This heterogeneity could be ex-
plained by causative genes that encode different com-
ponents of related metabolic pathways or by different
subunits of an enzyme complex. In databases, we have
not found evidence of functionally related proteins pre-
viously mapped within the three chromosomal adPEO
loci (GeneMap ’98). To date, two other autosomally
inherited diseases associated with mtDNA deletions have
been mapped to distinct nuclear regions. Wolfram syn-
drome is an autosomal recessive neurodegenerative dis-
order sometimes associated with single or multiple
mtDNA deletions, and it has been shown to be linked
to chromosome 4p (Polymeropoulos et al. 1994; Bar-
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Figure 3 Multipoint LOD-score calculation across the 4q
adPEO region. The dotted line represents the analyses done with in-
formation from the affected individuals, giving a maximum LOD score
of 3.8. The solid line indicates the multipoint calculations done when
data from clinically healthy individuals age 145 years were added,
giving a maximum LOD score of 4.7. The markers used in the cal-
culations are shown above the X-axis, and the intermarker distances
are shown between the markers.
rientos et al. 1996a, 1996b). The defective gene (WFS1)
was recently identified and it appears to function in the
survival of islet b-cells and neurons (Inoue et al. 1998).
A recessively inherited mitochondrial neurogastrointes-
tinal encephalomyopathy with multiple mtDNA dele-
tions was recently shown to be caused by mutations in
the thymidine-phosphorylase gene on chromosome
22q13.32-qter (Hirano et al. 1998; Nishino et al. 1999).
The clinical symptoms of the patients in the family
with linkage to 4q seem to be less severe than those in
families with linkage to 10q and 3p. The muscular symp-
toms are limited to facial muscles: all of the patients
presented with ophthalmoplegia and ptosis but with no
exercise intolerance or generalized muscle weakness.
Most patients had sensorineural hypoacusia, and some
had goiter or dementia. It remains uncertain whether the
latter symptoms are a result of the adPEO-gene defect,
because of the relatively high prevalence of these dis-
orders in the general population.
To date, ∼65 expressed sequence tags representing dif-
ferent genes have been localized to the 4q adPEO region,
and eight of these represent known genes (GeneMap
’98). The adenine nucleotide translocator is a key met-
abolic enzyme of the mitochondria, transporting ADP
and ATP across the inner mitochondrial membrane. The
gene for the heart- and muscle-specific isoform (ANT1)
has been localized to 4q35 (Fan et al. 1992). The ANT1
knockout mice showed ragged red muscle fibers and pro-
liferation of mitochondria, lactic acidosis, severe exercise
intolerance, and cardiomyopathy (Graham et al. 1997).
Our patients lacked the cardiac symptoms, but otherwise
the symptoms of the patients resembled those of ANT1
knock out mice, making ANT1 a good candidate gene
for adPEO. Whether ANT1 is involved in the patho-
genesis of adPEO is being analyzed. In addition, the gene
for dominantly inherited facioscapulohumeral muscular
dystrophy has been localized to the 4q adPEO region
(Wijmenga et al. 1990). adPEO and this dystrophy share
sensorineural hearing loss as a symptom of the disease,
but our patients had neither generalized muscle weak-
ness nor retinal changes. The eventual characterization
of the first adPEO gene will not only reveal one of the
pathogenic mechanisms causing the genetically hetero-
geneous disease but will also enhance the search for the
remaining adPEO genes and will improve our funda-
mental understanding of mtDNA stability and mainte-
nance in the cell.
Acknowledgments
The authors wish to thank Joseph Terwilliger for his valu-
able comments on linkage analysis. We also thank Ritva Ti-
monen, Anne Jokiaho, and Maikki Parkkonen for their skillful
technical assistance. This study was supported by grants from
the Finnish Medical Foundation, the Farmos Research and
Science Foundation, and the Finnish Muscular Disease Foun-
dation (to J.K.); from Telethon (grant 767 to M.Z.); from the
Academy of Finland (to L.P.); from the Emil Aaltonen Foun-
dation (to A.S.); and from the Hjelt Fond of the Pediatric
Research Foundation, Finland.
JYRKI KAUKONEN,1 MASSIMO ZEVIANI,2
GIACOMO PIETRO COMI,3 MARIA-GRAZIA PISCAGLIA,4
LEENA PELTONEN,1,* AND ANU SUOMALAINEN1
1National Public Health Institute, Department of
Human Molecular Genetics, Helsinki; 2National
Neurological Institute “Carlo Besta,” Division of
Biochemistry and Genetics, and 3Centro Dino Ferrari,
Istituto di Clinica Neurologica, Universita` degli Studi
di Milano, Instituto di Ricovero e Cura a Carattere
Scientifico, Ospedale Maggiore Policlinico, Milan; and
4Divisione di Neurologia, Ospedale degli Infermi,
Rimini, Italy
Electronic-Database Information
Accession numbers and URLs for data in this article are as
follows:
Cooperative Human Linkage Center, http://www.chlc.org/ (for
markers)
GeneMap ’98, http://www.ncbi.nlm.nih.gov/genemap/ (for
markers)
Genetic Location Database (LDB), http://cedar.genetics.soton
.ac.uk/public_html/index.html (for markers)
Online Mendelian Inheritance in Man (OMIM), http://www
260 Am. J. Hum. Genet. 65:256–261, 1999
.ncbi.nlm.nih.gov/Omim/ (for adPEO loci in a Finnish family
[MIM 157640], in three Italian families [MIM 601226], and
from other sources [MIM 601227])
References
Barrientos A, Casademont J, Saiz A, Cardellach F, Volpini V,
Solans A, Tolosa E, et al (1996a) Autosomal recessive Wolf-
ram syndrome associated with an 8.5-kb mtDNA single de-
letion. Am J Hum Genet 58:963–970
Barrientos A, Volpini V, Casademont J, Genis D, Manzanares
J-M, Ferrer I, Corral J, et al (1996b) A nuclear defect in the
4p16 region predisposes to multiple mitochondrial DNA
deletions in families with Wolfram syndrome. J Clin Invest
97:1570–1576
Cottingham RW Jr, Idury RM, Scha¨ffer AA (1993) Faster se-
quential genetic linkage computations. Am J Hum Genet 53:
252–263
Dib C, Faure´ S, Fizames C, Samson D, Drouot N, Vignal A,
Millasseau P, et al (1996) A comprehensive genetic map of
the human genome based on 5,264 microsatellites. Nature
380:152–154
Fan YS, Yang HM, Lin CC (1992) Assignment of the human
muscle adenine nucleotide translocator gene (ANT1) to
4q35 by fluorescence in situ hybridization. Cytogenet Cell
Genet 60:29–30
Graham BH, Waymire KG, Cottrell B, Trounce IA, MacGregor
GR, Wallace DC (1997) A mouse model for mitochondrial
myopathy and cardiomyopathy resulting from a deficiency
in the heart/muscle isoform of the adenine nucleotide trans-
locator. Nat Genet 16:226–234
Hirano M, Carcia-de-Yebenes J, Jones AC, Nishino I, Di-
Mauro S, Carlo JR, Bender AN, et al (1998) Mitochondrial
neurogastrointestinal encephalomyopathy syndrome maps
to chromosome 22q13.32-qter. Am J Hum Genet 63:
526–533
Inoue H, Tanizawa Y, Wasson J, Behn P, Kalidas K, Bernal-
Mizrachi E, Mueckler M, et al (1998) A gene encoding a
transmembrane protein is mutated in patients with diabetes
mellitus and optic atrophy (Wolfram syndrome). Nat Genet
20:143–148
Kaukonen JA, Amati P, Suomalainen A, Ro¨tig A, Piscaglia M-
G, Salvi F, Weissenbach J, et al (1996) An autosomal locus
predisposing to multiple deletions of mtDNA on chromo-
some 3p. Am J Hum Genet 58:763–769
Lathrop GM, Lalouel JM, Julier C, Ott J (1984) Strategies for
multilocus linkage analysis in humans. Proc Natl Acad Sci
USA 81:3443–3446
Melberg A, Lundberg PO, Henriksson KG, Olsson Y, Sta¨lberg
E (1996) Muscle-nerve involvement in autosomal dominant
progressive external ophthalmoplegia with hypogonadism.
Muscle Nerve 19:751–757
Nishino I, Spinazzola A, Hirano M (1999) Thymidine phos-
phorylase gene mutations in MNGIE, a human mitochon-
drial disorder. Science 283:689–692
Ott J (1989) Computer-simulation methods in human linkage
analysis. Proc Natl Acad Sci USA 86:4175–4178
Polymeropoulos MH, Swift RG, Swift M (1994) Linkage of
the gene for Wolfram syndrome to markers on the short arm
of chromosome 4. Nat Genet 8:95–97
Scha¨ffer AA, Gupta SK, Shiriram K, Cottingham RW Jr (1994)
Avoiding recomputation in linkage analysis. Hum Hered 44:
225–237
Servidei S, Zeviani M, Manfredi G, Ricci E, Silvestri G, Bertini
E, Gellera C, et al (1991) Dominantly inherited mitochon-
drial myopathy with multiple deletions of mitochondrial
DNA: clinical, morphologic and biochemical studies. Neu-
rology 41:1053–1059
Suomalainen A, Kaukonen J, Amati P, Timonen R, Haltia M,
Weissenbach J, Zeviani M, et al (1995) An autosomal locus
predisposing to deletions of mitochondrial DNA. Nat Genet
9:146–151
Suomalainen A, Majander A, Haltia M, Somer H, Lo¨nnqvist
J, Savontaus ML, Peltonen L (1992) Multiple deletions
of mitochondrial DNA in several tissues of a patient with
severe retarded depression and familial progressive external
ophthalmoplegia. J Clin Invest 90:61–66
Suomalainen A, Majander A, Wallin M, Setala K, Kontula K,
Leinonen H, Salmi T, et al (1997) Autosomal dominant pro-
gressive external ophthalmoplegia with multiple deletions of
mtDNA: clinical, biochemical, and molecular genetic fea-
tures of the 10q-linked disease. Neurology 48:1244–1253
Weeks DE, Ott J, Lathrop GM (1990) SLINK: a general sim-
ulation program for linkage analysis. Am J Hum Genet
Suppl 47:A204
Wijmenga C, Frants RR, Brouwer OF, Moerer P, Weber
JL, Padberg GW (1990) Location of facioscapulohumeral
muscular dystrophy gene on chromosome 4. Lancet 336:
651–653
Zeviani M, Bresolin N, Gellera C, Bordoni A, Pannacci M,
Amati P, Moggio M, et al (1990) Nucleus-driven multi-
ple large-scale deletions of the human mitochondrial ge-
nome: a new autosomal dominant disease. Am J Hum Genet
47:904–914
Zeviani M, Moraes CT, DiMauro S, Nakase H, Bonilla E,
Schon EA, Rowland LP (1988) Deletions of mitochondrial
DNA in Keyrns-Sayre syndrome. Neurology 38:1339–1346
Zeviani M, Servidei S, Gellera C, Bertini E, DiMauro S,
DiDonato S (1989) An autosomal dominant disorder with
multiple deletions of mitochondrial DNA starting at the D-
loop region. Nature 339:309–311
Address for correspondence and reprints: Dr. Jyrki Kaukonen, National Public
Health Institute, Department of Human Molecular Genetics, Mannerheimintie
166, 00300 Helsinki, Finland. E-mail: Jyrki.Kaukonen@ktl.fi
∗ Present affiliation: Department of Human Genetics, University of California
School of Medicine, Los Angeles.
 1999 by The American Society of Human Genetics. All rights reserved.
0002-9297/99/6501-0035$02.00
